UPDATED Mar 17, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ZVRA | US$6.00 | -2.1% | 21.2% | US$248.9m | US$18.25 | PS15x | E59.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$3.11 | -10.6% | 5.8% | US$162.3m | US$8.50 | PS2x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$16.43 | -0.06% | 24.4% | US$423.3m | US$26.49 | PS8.4x | E64.0% | n/a | Pharmaceuticals & Biotech | ||
FTCI | US$0.44 | -7.2% | -78.1% | US$55.5m | n/a | PB0.9x | E64.7% | n/a | Capital Goods | ||
PESI | US$9.25 | 7.9% | 3.2% | US$126.5m | US$19.00 | PE137.8x | E132.5% | n/a | Commercial Services | ||
CCB | US$36.20 | -4.8% | -1.3% | US$484.4m | US$54.38 | PB1.6x | E31.0% | n/a | Banks | ||
IREN | US$4.60 | -9.4% | 52.3% | US$478.6m | US$11.07 | PS3.9x | E105.2% | n/a | Software | ||
NETI | US$11.33 | 0.09% | 12.7% | US$415.0m | US$15.21 | PS2.7x | E90.6% | 0.4% | Capital Goods | ||
ACTD | US$7.79 | -24.2% | -21.2% | US$303.0m | US$17.00 | PE-25.3x | E85.2% | n/a | Diversified Financials | ||
LOOP | US$2.69 | -2.5% | 26.3% | US$127.9m | US$6.65 | PS1058.1x | E63.8% | n/a | Materials | ||
GPMT | US$4.79 | 0% | -5.3% | US$243.3m | US$6.00 | PB0.3x | E143.3% | 16.7% | Diversified Financials | ||
HOFV | US$3.66 | 4.0% | -57.1% | US$23.6m | US$12.00 | PS1.1x | E61.0% | n/a | Consumer Services | ||
MVST | US$0.55 | -21.2% | -54.5% | US$173.5m | US$8.75 | PB0.3x | E58.3% | n/a | Capital Goods | ||
SMTI | US$37.00 | 1.4% | -6.9% | US$315.9m | US$49.00 | PS5x | E165.6% | n/a | Healthcare | ||
URGN | US$14.46 | -15.4% | 70.1% | US$493.4m | US$38.50 | PS6x | E62.4% | n/a | Pharmaceuticals & Biotech | ||
OPTN | US$1.88 | 1.1% | 11.2% | US$211.8m | US$3.50 | PS3x | E61.6% | n/a | Pharmaceuticals & Biotech | ||
CAPR | US$6.39 | 10.2% | 42.6% | US$200.6m | US$21.00 | PS8x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
CKPT | US$1.92 | -10.7% | -46.2% | US$71.4m | US$18.25 | PS417.5x | E80.4% | n/a | Pharmaceuticals & Biotech | ||
DUOT | US$4.33 | 3.7% | 48.3% | US$31.6m | US$6.75 | PS2.7x | E74.1% | n/a | Software | ||
CHMI | US$3.43 | 1.2% | -38.6% | US$104.9m | US$5.50 | PB0.7x | E125.5% | 17.5% | Diversified Financials | ||
ALDX | US$2.79 | -14.2% | -62.5% | US$164.3m | US$9.40 | PB1.4x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
ENSC | US$0.79 | 3.5% | -88.2% | US$5.8m | US$13.60 | PS2.6x | E62.6% | n/a | Pharmaceuticals & Biotech | ||
AGRX | US$0.54 | -24.4% | -94.8% | US$1.6m | US$5.00 | PE-0.1x | E57.9% | n/a | Pharmaceuticals & Biotech | ||
MYO | US$3.58 | -1.9% | 496.7% | US$102.0m | US$6.79 | PS5.3x | E63.9% | n/a | Healthcare |